Issuance contents for stock options have been finalized. Recipients: 52 people; total issued: 121,356 units; shares subject to exercise: common shares 12,135,600.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4593","jir_company_name":"Human Therapeutics Corporation","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-07-02","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/4593-20260702-02.pdf","jir_short_summary":"Issuance contents for stock options have been finalized. Recipients: 52 people; total issued: 121,356 units; shares subject to exercise: common shares 12,135,600.","jir_summary":"### Section Heading\nThis notice announces that, based on the resolution of the Board of Directors meeting held on June 17, 2026, the previously undecided issuance contents for the stock options have been finalized. The recipients consist of directors, executive officers, employees, and directors\/employees of subsidiaries, totaling 52 individuals. The total allocation is 121,356 units, and the shares subject to exercise are 12,135,600 common shares.\n\n### Section 2 Heading\nThis matter is being implemented as part of the capital policy and remuneration system, and details such as specific exercise conditions and exercise periods will be disclosed separately. The future schedule and market impact are currently unknown, and investors should monitor progress of exercise and potential dilution effects.","jir_financial_highlights":"Total number of stock options: 121,356 (Unknown)\nType and number of shares for the stock options: Common shares 12,135,600 shares (Unknown)\nNumber of recipients: 52 people (Unknown)","jir_category":"","jir_hashtags":"#Human Therapeutics Corporation, #stock_option, #JapaneseStocks","jir_key_figures":"Total number of stock options: 121,356\nType of shares: Common shares\nNumber of shares subject to exercise: 12,135,600 shares\nNumber of recipients: 52 people","jir_meta_title":"\u3010Human Therapeutics Corporation\u3011Finalization of Issuance Content for Paid Stock Options | July 2026","jir_meta_description":"Finalization of issuance contents for paid stock options. Recipients: 52, total: 121,356 units, underlying shares: 12,135,600 common shares. Watch for future exercise conditions and additional details.","jir_og_title":"\u3010Human Therapeutics Corporation\u3011Stock Option Issuance Content Finalized | July 2026","jir_og_description":"Issuance content for stock options finalized. Recipients 52, total 121,356 units, shares subject to exercise 12,135,600. Focus on future exercise conditions.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57247,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-75278","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n